用超过方法在人体和小鼠血中表征化学多样化的抗意义寡核酸的血蛋白结合特征
Cassandra Yun1, Kazuki Fukami2, Raku Shinkyo1
1Eisai, Cambridge, MA, United States.
Frontiers in pharmacology
|February 6, 2025
概括
修改的反感性寡核酸 (ASO) 显示出不同的血蛋白结合. 二胺酸形态寡合物 (PMOs) 的结合率低于2'-O-甲乙烯/二酸 (MOE/PS) 修饰的ASOs,而人类马球蛋白是关键的结合剂.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
- 氧核酸治疗药物 治疗药物
背景情况:
- 血蛋白结合显著影响药物的药理动力学和药理动力学.
- 反感性寡核酸 (ASOs) 是一个有前途的治疗方式,但它们与血蛋白结合需要进行彻底的研究.
研究的目的:
- 为了比较两个主要的ASO化学物质的血蛋白结合概况:二胺酸形烯酸寡合物 (PMOs) 和2'-O-甲乙烯/二酸 (MOE/PS) 修改的ASOs.
- 为了确定负责ASO结合的关键血蛋白.
主要方法:
- 超过与混合化电化学发光相结合,用于测量小鼠和人类血中ASO的未结合分数 (fu).
- 评估了ASO与主要人体血蛋白 (HSA,AAG,IgG,LDL,HDL) 的个别结合亲和力.
主要成果:
- 经MOE/PS修改的ASO表现出明显高于PMO的血蛋白结合.
- 在小鼠和人体血之间没有观察到结合的显著物种差异.
- 人类马环球蛋白 (IgG) 对两种ASO类型都表现出主要的结合亲和力,超过了人体血清白蛋白 (HSA).
结论:
- ASO化学和修改是血蛋白结合的关键决定因素.
- 人类马环球蛋白在ASO血蛋白结合中起着重要的,但经常被忽视的作用.
- 了解这些结合相互作用对于优化ASO分布,组织处置和治疗疗效至关重要.
相关概念视频
01:29Drug Distribution: Plasma Protein Binding
4.8K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
4.8K
01:22Protein-Drug Binding: Determination Methods
109
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
109
01:20Factors Affecting Protein-Drug Binding: Protein-Related Factors
112
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
112
01:13Physiological Pharmacokinetic Models: Assumption with Protein Binding
30
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
30
01:22Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
113
When a drug follows nonlinear pharmacokinetics, its bioavailability, the amount of the drug that reaches the systemic circulation, can change with different doses. This is due to the presence of a saturable pathway. The pathway becomes saturated as the drug concentration increases, decreasing the absorption rate. Consequently, the drug's bioavailability may be lower than expected at higher doses.
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
113
01:18Factors Affecting Protein-Drug Binding: Drug-Related Factors
73
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
73